Abstract
Background: Given increased effectiveness and adoption of neoadjuvant chemotherapy (NAT) for pancreatic adenocarcinoma (PDAC), there has been increased willingness to explore borderline and locally advanced patients for resection that may include venous and/or arterial resection. We hypothesized that with careful patient selection, and a team approach including transplant surgery and vascular surgery, perioperative outcomes would be comparable to reported outcomes. The aim of the study was to examine our recent indications and outcomes for pancreatectomy with vascular resection.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
